April Lewis currently leads the technology strategy for GSK’s Trial Operations and Site Engagement portfolio. Prior to joining GSK, April served at the GM for IQVIA’s Clinical Trial Optimization Solutions, was a member of the Executive Merger Team for Quintiles/IMS, and led several performance improvement and transformation exercises in clinical operations for Covance, RapidTrials, Merck and Wyeth.
April holds an M.S from Saint Joseph’s University in Organizational Development and Organizational Psychology.
More than 25 years of hands-on experience and working knowledge in clinical development and operations in both diagnostics and therapeutics at the Senior Director and Vice President capacity. Track record includes delivering supportive clinical data culminating in multiple NDA/BLA and PMA/510(k) product approvals in the US and EU. Experienced in leading highly motivated in-house clinical and cross-functional teams, vendors and CROs in strategic planning and execution of early to late phase clinical trials in oncology, immunotherapy, CNS, CVD and upper respiratory disorders in a cost-effective and timely manner. Experienced in planning and executing complex, hard to recruit, large global studies across 5 continents. Authored publications, protocols, study documents, training material and mentored direct reports.
Mark Milberg has over 27 years of management and operational experience in the biopharmaceutical, medical device, and healthcare industries. He currently works as Senior Director, Clinical Outsourcing at Ultragenyx Pharmaceutical Inc., supporting all of the clinical programs in this clinical-stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases. He worked at Medtronic previously for 8 years in increasingly responsible positions, including leading the contract function for the entire company. Mark’s career has included work in medical and dental practice management as well. He has both a MSW and a MBA. He was appointed to his local community’s Citizen Finance Oversight/Advisory Committee. Mark has presented at numerous industry conferences and is a well-respected collaborator and influencer in his field.
Jacqueline Lee has been working in the clinical research industry for over 30 years. She brings a unique perspective in that she has worked in several different capacities, including at the site level, the CRO level, and the Sponsor side of this industry.
For the past 17 years, Jacqueline has been working at Cytokinetics, a biopharmaceutical company located in South San Francisco, California. She is currently the Senior Director of Clinical Operations and has provided strategic planning, leadership, and oversight for over 35 clinical trials, the majority of which were conducted internationally.
Sumant joined CGI in Dec 2018 as Director of Digital Transformation in the newly created Emerging Technology practice and is responsible for developing strategy & capability in areas like Advanced Analytics, AI, Intelligent Automation, Cloud Native & Blockchain. Before joining CGI, Sumant worked as Head of Engagement in the CIO team for Santander Bank – responsible for shaping and leading various digital transformation initiatives. Prior to this Sumant has worked in global technology firms like IBM and Sapient. Sumant is also a proud alumni of Cranfield University (Full time MBA, 2010-2011).
Eloise has been working at ABB for 6 years, joining as a Process Engineer in 2014, and then moving into a Process Safety Engineer role. Since then, Eloise has moved into a digital role as Safety Lifecycle Management Subject Matter Expert for a number of Process Safety related digital solutions. Included within this role Eloise developed as the Technical Product Manager for ABB’s HAZOP and LOPA SafetyInsight Digital modules. Eloise is focussed on ensuring ABB is successful at supporting and delivering value to customers on their digital journey.
Anders Mortin started in the pharmaceutical industry in 1992, working with data management at Clinical Data Care (Now TFS) in Lund, Sweden.
Having had roles as Clinical Data Manager, Project Manager and eSolutions Manager at TFS he joined H. Lundbeck (Copenhagen, Denmark) in 2003 as Systems Project Manager.
In 2006 Anders was appointed eClinical Program Manager at Lundbeck, responsible for a portfolio of technology implementation projects in clinical development.
Anders joined Ferring Pharmaceuticals in 2009 as Director of Clinical Data Management, focusing on globalization of biometrics processes, establishment of an offshore organisations and cross functional alignment of processes and methodology.
In 2015 Anders co-founded TriTiCon, a consulting company that combining the Three Tiers of strategic advice, project management and subject matter knowledge to help customers with strategic development, change and implementations.
At TriTiCon, Anders is leading the team of consultants, specializing in helping clients source services and select & implement systems for collection, handling and reporting of clinical data.
With over 16 years’ experience in various executive positions at Mast-Jägermeister, Marcus Thieme now brings a wealth of experience that fits perfectly with BrewDog’s aspirations and ambitious expansion plans. The focus of his responsibilities are to drive growth in key international markets pushing the company forward into strong positions supported by his strategical decisions and strong background in sales and marketing.
Co-Founder, Clinical Research Innovation Hub, Microsoft Corporation
The Clinical Research Innovation Hub (CRIH) is the first industry focused internal startup in Microsoft. Innovation hubs are engines that allow Microsoft to focus on pressing industry problems by combining the speed, agility and autonomy of a startup with resources available to a large enterprise. CRIH analyzes problems deeply through interviews and experiments, then rapidly builds solutions alongside Microsoft customers and partners.
Ryan is responsible for the operations of the innovation hub, for the management of the portfolio, and for creating the conditions for agile and open innovation. CRIH is enabling Microsoft and its partners to conceptualize, incubate, and ultimately deliver the technology innovations that will drive the adoption of new clinical research paradigms.
Ryan has been with Microsoft for 12 years. Prior to his current role he served as a Chief Transformation Officer for the US subsidiary, responsible for designing and executing change management strategies for transforming sales, marketing, and services operations for the $33B business.
Before joining Microsoft, Ryan was the CIO for the City of Chicago city council, responsible for implementing IT policies and data security protocols to protect the integrity of sensitive citizen and employee data. He partnered with Microsoft and implementation partners to modernize and transform dozens of legacy systems, enabling greater transparency in government and more citizen-centric applications.
Ryan holds a Bachelor of Science in Chemical Engineering from North Carolina State University and a Master of Business Administration from Duke University (The Fuqua School of Business).
Co-Founder, Clinical Research Innovation Hub, Microsoft Corporation
The Clinical Research Innovation Hub (CRIH) is the first industry focused internal startup in Microsoft. Innovation hubs are engines that allow Microsoft to focus on pressing industry problems by combining the speed, agility and autonomy of a startup with resources available to a large enterprise. CRIH analyzes problems deeply through interviews and experiments, then rapidly builds solutions alongside Microsoft customers and partners.
Paul is responsible for the strategy of the innovation hub, for establishing a target technology architecture for clinical research, and for building partnerships within and outside of Microsoft that realize the transformation vision. Microsoft and its partners are building solutions that will allow end-to-end digitization of the study, maximize the value of research data and ensure patient needs are met as research modernizes.
Paul has been at Microsoft for 8 years. Prior to his current role he worked as Worldwide Director of Industry Strategy for Life Sciences, and as a Director of Enterprise Architecture, focused on developing incubation solutions in the life sciences industry and multiple other industries, including energy production, discrete manufacturing, financial services and education.
Before joining Microsoft, Paul was a Senior Enterprise Architect at Weyerhaeuser – a global forest products company. He was responsible for the overall technology architecture of the organization, developed Weyerhaeuser’s virtualization, cloud and security strategies, and defined a target architecture for shared services across multiple lines of business.
He is the author or co-author of multiple papers and books on both health and technology issues. He has delivered keynote addresses at multiple conferences in the United States and Europe, including CDISC Interchange, BME Global Pharma Supply Chain Congress, Parexel Horizons, and the Society for Clinical Data Management. He holds a Bachelor of Science (Hons) in Mathematics from King’s College. London.
